TNSN06299A1 - Oral matrix formulations comprising licarbazepine - Google Patents

Oral matrix formulations comprising licarbazepine

Info

Publication number
TNSN06299A1
TNSN06299A1 TNP2006000299A TNSN06299A TNSN06299A1 TN SN06299 A1 TNSN06299 A1 TN SN06299A1 TN P2006000299 A TNP2006000299 A TN P2006000299A TN SN06299 A TNSN06299 A TN SN06299A TN SN06299 A1 TNSN06299 A1 TN SN06299A1
Authority
TN
Tunisia
Prior art keywords
licarbazepine
matrix formulations
oral matrix
oral
formulations
Prior art date
Application number
TNP2006000299A
Other languages
French (fr)
Inventor
Marie-Christine Wolf
Oskar Kalb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/002988 external-priority patent/WO2005092294A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TNSN06299A1 publication Critical patent/TNSN06299A1/en

Links

Abstract

THE INVENTION RELATES TO PHARMACEUTICAL COMPOSITIONS COMPRISING 10,11-DIHYDRO-10-HYDROXY-5H-DIBENZ,[B,F]AZEPINE-5-CARBOXAMIDE (ALSO REFERRED TO AS "LICARBAZEPINE") AS DRUG SUBSTANCE.
TNP2006000299A 2004-03-22 2006-09-21 Oral matrix formulations comprising licarbazepine TNSN06299A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0406379A GB0406379D0 (en) 2004-03-22 2004-03-22 Organic compounds
PCT/EP2005/002988 WO2005092294A1 (en) 2004-03-22 2005-03-21 Oral matrix formulations comprising licarbazepine

Publications (1)

Publication Number Publication Date
TNSN06299A1 true TNSN06299A1 (en) 2007-12-03

Family

ID=32118143

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000299A TNSN06299A1 (en) 2004-03-22 2006-09-21 Oral matrix formulations comprising licarbazepine

Country Status (3)

Country Link
CN (1) CN1933819A (en)
GB (1) GB0406379D0 (en)
TN (1) TNSN06299A1 (en)

Also Published As

Publication number Publication date
GB0406379D0 (en) 2004-04-21
CN1933819A (en) 2007-03-21

Similar Documents

Publication Publication Date Title
NO20064808L (en) Oral matrix formulations with licarbazepine
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
BR0015188A (en) Pharmaceutical compositions
HK1076605A1 (en) Formulations
IL173571A0 (en) Injectable, oral, or topical sustained release pharmaceutical formulations
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
ECSP066872A (en) DISINTEGRANT TABLETS UNDERSTANDING LICARBAZEPINA
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
AP2005003375A0 (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them.
ATE286894T1 (en) 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS
UA87152C2 (en) Solid pharmaceutical composition containing mirtazapine and method for preparation thereof
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
ZA200501010B (en) BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
AU2003202550A1 (en) Pharmaceutical formulations with modified release
GB0327390D0 (en) Pharmaceutical formulations
EP1697335A4 (en) Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them
TNSN06298A1 (en) Disintegrating tablets comprising licarbazepine
WO2001095890A3 (en) Oral pharmaceutical compositions containing terbinafine
TNSN08442A1 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
MD20040296A (en) Pharmaceutical composition containing oxcarbazepin with prolonged release of the active ingredient